FTXH

First Trust Nasdaq Pharmaceuticals ETF

Up$20.75
+$0.14
(+0.66%)
As of 6:55:00 PM EDT | 9/12/19  |  Market Closed

FTXH Trading Data

Open

$20.75

Low Price

$20.75

High Price

$20.75

Previous Last Price

$20.61

Bid Size

$0 X 0

Ask Size

$0 X 0

FTXH Portfolio Data

AUM

$7,213,500

Shares

350

PE Ratio

20.96

Price / Book Ratio

4.07

Expense Ratio

0.6

Net Asset Value

$20.61

Volume

Volume

300

Avg. Volume (YDT)

2,875

Dollar Volume

$0

Weekly Avg. Volume

260

Monthly Avg. Volume

935

Quarterly Avg. Volume

2,164

FTXH Fund Description

The First Trust Nasdaq Pharmaceuticals ETF is an exchange-traded fund. The investment objective of the Fund is to seek investment results that correspond generally to the price and yield, before the Fund's fees and expenses, of an index called the Nasdaq US Smart Pharmaceuticals Index. The Fund seeks to replicate the holdings and weightings of the Nasdaq US Smart Pharmaceuticals Index so as to generate performance results 95% correlated to that of the Nasdaq US Smart Pharmaceuticals Index.

FTXH Chart

FTXH Summary

Fund Family

First Trust Portfolios

Tracks This Index

First Trust Nasdaq Pharmaceuticals ETF

Inception Date

2016-09-20

Asset Class

Equity

Asset Class Size

Large Cap

FTXH Classification

Region (General)

North America

Region (Specific)

US

Sector

Equity Index

Leveraged Family

FTXH Holdings

Top 10 Holdings

Zoetis Inc. (ZTS)
9.44%
Merck & Co. Inc. (MRK)
7.99%
Johnson & Johnson (JNJ)
7.66%
Eli Lilly and Company (LLY)
7.43%
Pfizer Inc. (PFE)
6.98%
Horizon Therapeutics Plc (HZNP)
4.31%
Catalent Inc. (CTLT)
4.28%
Abbott Laboratories (ABT)
4.24%
Bristol-Myers Squibb Company (BMY)
4.15%
Jazz Pharmaceuticals Plc (JAZZ)
3.92%

Total FTXH Holdings

Total Holdings: 31

Zoetis Inc. (ZTS)
9.44%
Merck & Co. Inc. (MRK)
7.99%
Johnson & Johnson (JNJ)
7.66%
Eli Lilly and Company (LLY)
7.43%
Pfizer Inc. (PFE)
6.98%
Horizon Therapeutics Plc (HZNP)
4.31%
Catalent Inc. (CTLT)
4.28%
Abbott Laboratories (ABT)
4.24%
Bristol-Myers Squibb Company (BMY)
4.15%
Jazz Pharmaceuticals Plc (JAZZ)
3.92%
AbbVie Inc. (ABBV)
3.44%
Innoviva Inc. (INVA)
3.28%
Allergan Plc (AGN)
3.25%
Corcept Therapeutics Incorporated (CORT)
2.24%
The Medicines Company (MDCO)
2.2%
Mylan N.V. (MYL)
2.19%
Perrigo Company Plc (PRGO)
2.11%
Heron Therapeutics Inc. (HRTX)
1.95%
Madrigal Pharmaceuticals Inc. (MDGL)
1.88%
Zogenix Inc. (ZGNX)
1.81%
Alkermes Plc (ALKS)
1.73%
Vanda Pharmaceuticals Inc. (VNDA)
1.63%
Blueprint Medicines Corporation (BPMC)
1.61%
Supernus Pharmaceuticals Inc. (SUPN)
1.57%
Sage Therapeutics Inc. (SAGE)
1.49%
Amicus Therapeutics Inc. (FOLD)
1.48%
Ironwood Pharmaceuticals Inc. (IRWD)
1.45%
Pacira BioSciences Inc. (PCRX)
1.42%
Endo International Plc (ENDP)
1.36%
Esperion Therapeutics Inc. (ESPR)
1.31%
First Trust Nasdaq Pharmaceuticals ETF (FTXH)
0%

FTXH Technicals

Alpha

0

Beta

1.02

Leverage

Long

Standard Deviation

1

FTXH Dividends

Dividend Date

2019-06-14

Latest Dividend

0.04

Annual Dividend

0.13

Annual Dividend Rate

0.13

Annual Dividend Yield

0.63

FTXH Performance

YTD Return

8%

1 Year Return

-10.81%

3 Year Return

0%

5 Year Return

0%

10 Year Return

5.2%

FTXH Related Articles